No phaseRecruiting
Pancreatic Cancer Screening in a Population at High Risk (ScrePan)
- Sponsor
- Masaryk Memorial Cancer Institute (Academic or other)
- Enrolment
- 700 planned
- Conditions
- Pancreatic Ductal Adenocarcinoma; Hereditary Diseases; Pancreatitis, Chronic
- Interventions
- endoscopic ultrasonography; magnetic resonance; laboratory examination
- Ages
- adults, older adults
- Registry
- NCT06330441
Full record on ClinicalTrials.gov
From the registry
Pancreatic cancer is one of the diseases with the worst prognosis, which is mainly due to the initial asymptomatic prognosis. Unfortunately, the incidence of this disease in the Czech Republic is still increasing. In a certain proportion of patients, it is possible to predict the disease, e.g. due to family burdens. Regular follow-up of such individuals is the subject of the SCREPAN study: "Pancreatic Cancer Screening in High-Risk Persons".
Primary outcomes
- Number of participants with newly diagnosed pancreatic ductal adenocarcinoma
History
Study completion expected
Primary completion expected
Last registry update
Registered
Started